Cargando…
Novel treatments for inflammatory bowel disease
Increased understanding of the immunopathology of inflammatory bowel disease (IBD) has led to the development of targeted therapies and has unlocked a new era in IBD treatment. The development of treatment options aimed at a variety of pathological mechanisms offers new hope for customized therapies...
Autores principales: | Lee, Hyo Sun, Park, Soo-Kyung, Park, Dong Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768553/ https://www.ncbi.nlm.nih.gov/pubmed/29223139 http://dx.doi.org/10.3904/kjim.2017.393 |
Ejemplares similares
-
Current status of biosimilars in the treatment of inflammatory bowel diseases
por: Park, Dong Il
Publicado: (2016) -
An immune therapy model for effective treatment on inflammatory bowel disease
por: Park, Anna, et al.
Publicado: (2020) -
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease
por: Na, Soo-Young, et al.
Publicado: (2019) -
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
por: Park, Soo-Kyung, et al.
Publicado: (2020) -
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
por: Kim, You Sun, et al.
Publicado: (2023)